A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia

Introduction Behavioural variant frontotemporal dementia (bvFTD) is a neurodegenerative disorder often neuropathologically associated with the accumulation of abnormally hyperphosphorylated tau, for which there is currently no disease-modifying treatment. Previous work by our group has shown sodium...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Rebekah M Ahmed, Lucy Vivash, Dennis Velakoulis, Leonid Churilov, Olivier Piguet, David Darby, Terence J O'Brien, Charles B Malpas, Mark Walterfang, Amy Brodtmann, Ashley I Bush, Christopher M Hovens, T Kalincik
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMJ Publishing Group 2020-11-01
Edice:	BMJ Open
On-line přístup:	https://bmjopen.bmj.com/content/10/11/e040100.full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!